Literature DB >> 1009939

Kinetics of thyroglobulin iodination and of hormone synthesis catalysed by thyroid peroxidase. Role of iodide in the coupling reaction.

D Dème, J Pommier, J Nunez.   

Abstract

The kinetics of tyrosine iodination and of thyroxine synthesis in thyroglobulin, different reactions catalyzed by the same enzyme (thyroid peroxidase), have been compared. Thyroxine synthesis always began after a lag period of 3-5 min. This lag was constant whatever the rate of iodination; this rate of iodination was increased either by increasing the concentration of iodide or enzyme or by decreasing the concentration of thyroglobulin. Increasing the rate of iodination resulted in increasing the number of iodine atoms incorporated during the lag period. Thus the lag observed for thyroxine synthesis was constant and did not depend on the fact that free iodide or non-iodinated tyrosine residues of thyroglobulin were exhausted before thyroxine synthesis occurred. Finally, it appeared that, whatever the explanation of the lag, the enzyme catlyzes thyroid hormone synthesis at a slower rate than iodination. The existence of a lag also allowed us to prepare thyroglobulin samples with different iodine contents but without thyroid hormones. Thus iodination and thyroxine synthesis could be studied independently and the following results were obtained. 1. Iodotyrosine residues which can couple to form thytoxine are made considerably before coupling occurs. 2. H2O2 is required for coupling of these hormonogenic residues; thus the coupling reaction requires enzymic oxidation of the iodotyrosine residues. 3. In addition a strict requirement for iodide was needed for coupling; the requirement was dependent on the concentration of iodide. Thus iodide, a substrate of the iodination reaction, may also have other effects on the activity of thyroid peroxidase.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1009939     DOI: 10.1111/j.1432-1033.1976.tb11034.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Regulation of herpes simplex virus type 1 thymidine kinase gene expression by thyroid hormone receptor in cultured neuronal cells.

Authors:  Shao-Chung V Hsia; Rajeswara C Pinnoji; Gautam R Bedadala; James M Hill; Jayavardhana R Palem
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

2.  A Novel Thyroid Hormone Mediated Regulation of HSV-1 Gene Expression and Replication is Specific to Neuronal Cells and Associated with Disruption of Chromatin Condensation.

Authors:  Feng Chen; Jay Palem; Matthew Balish; Robert Figliozzi; Amakoe Ajavon; S Victor Hsia
Journal:  SOJ Pharm Pharm Sci       Date:  2014

3.  Dyshormonogenetic goiter: presence of an inhibitor of normal human thyroid peroxidase.

Authors:  D Rosenthal; D P Carvalho-Guimarães; M Knobel; G A Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

4.  Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells.

Authors:  Gautam R Bedadala; Rajeswara C Pinnoji; Jayavardhana R Palem; Shao-Chung V Hsia
Journal:  Cell Res       Date:  2010-04-13       Impact factor: 25.617

5.  Intracellular adhesion molecule-1 up-regulation on thyrocytes by iodine of non-obese diabetic.H2(h4) mice is reactive oxygen species-dependent.

Authors:  R Sharma; K Traore; M A Trush; N R Rose; C Lynne Burek
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

6.  Dual binding mode of antithyroid drug methimazole to mammalian heme peroxidases - structural determination of the lactoperoxidase-methimazole complex at 1.97 Å resolution.

Authors:  Rashmi Prabha Singh; Avinash Singh; Harsh Vardhan Sirohi; Amit Kumar Singh; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  FEBS Open Bio       Date:  2016-06-14       Impact factor: 2.693

7.  Structure-function relationship in thyroglobulin: amino acid sequence of two different thyroxine-containing peptides from porcine thyroglobulin.

Authors:  C Marriq; M Rolland; S Lissitzky
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.